Gufic BioSciences
Gufic Biosciences Performance
Day Range
- Low 285.6
- High 295.9
52 Week Range
- Low 177.65
- High 333
- Open Price287.6
- Previous Close286.75
- Volume105354
Start SIP in Gufic BioSciences
Start SIPGufic Biosciences Investment Rating
-
Master Rating:
-
Gufic Biosciences has an operating revenue of Rs. 720.36 Cr. on a trailing 12-month basis. An annual revenue de-growth of -11% needs improvement, Pre-tax margin of 15% is great, ROE of 22% is exceptional. The company has a debt to equity of 55%, which is bit higher. The stock from a technical standpoint is trading close to its 50DMA and comfortably placed above its 200DMA, around 25% above 200DMA. It needs to take support around the 50 DMA level to continue further upside move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 81 which is a GOOD score indicating consistency in earnings, a RS Rating of 68 which is FAIR indicating the recent price performance, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 87 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
Indicator | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
---|---|---|---|---|---|---|
Oper Rev Qtr Cr | 195 | 173 | 177 | 175 | 165 | 162 |
Operating Expenses Qtr Cr | 160 | 141 | 144 | 142 | 132 | 131 |
Operating Profit Qtr Cr | 35 | 32 | 33 | 33 | 33 | 32 |
Depreciation Qtr Cr | 4 | 6 | 5 | 5 | 4 | 4 |
Interest Qtr Cr | 4 | 3 | 2 | 2 | 1 | 1 |
Tax Qtr Cr | 7 | 6 | 7 | 7 | 7 | 6 |
Net Profit Qtr Cr | 21 | 18 | 20 | 20 | 21 | 20 |
Gufic Biosciences Technicals
EMA & SMA

- Bullish Moving Average
- ___
- 9
- Bearish Moving Average
- ___
- 7
- 20 Day
- ₹289.66
- 50 Day
- ₹278
- 100 Day
- ₹258.68
- 200 Day
- ₹240.59
- 20 Day
- ₹296.36
- 50 Day
- ₹279.94
- 100 Day
- ₹248.3
- 200 Day
- ₹229.19
Gufic Biosciences Resistance and Support
Resistance | |
---|---|
First Resistance | ₹293.34 |
Second Resistance | ₹299.77 |
Third Resistance | ₹303.64 |
RSI | 49.01 |
MFI | 65.8 |
MACD Single Line | 3.16 |
MACD | 0.64 |
Support | |
---|---|
First Resistance | ₹283.04 |
Second Resistance | ₹279.17 |
Third Resistance | ₹272.74 |
Gufic Biosciences Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 114,832 | 3,119,985 | 27.17 |
Week | 111,783 | 4,394,198 | 39.31 |
1 Month | 300,449 | 10,873,254 | 36.19 |
6 Month | 270,523 | 11,616,252 | 42.94 |
Gufic Biosciences Result Highlights
Gufic BioSciences Synopsis
NSE-Medical-Generic Drugs
Gufic Biosciences Lt is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 690.62 Cr. and Equity Capital is Rs. 9.69 Cr. for the Year ended 31/03/2023. Gufic BioSciences Ltd. is a Public Limited Listed company incorporated on 23/07/1984 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24100MH1984PLC033519 and registration number is 033519.Market Cap | 2,781 |
Sales | 720 |
Shares in Float | 2.42 |
No of funds | 11 |
Yield | 0.03 |
Book Value | 8 |
U/D Vol ratio | 1.6 |
LTDebt / Equity | 55 |
Alpha | 0.1 |
Beta | 0.73 |
Gufic BioSciences
Owner Name | Jun-23 | Mar-23 | Dec-22 | Sep-22 |
---|---|---|---|---|
Promoters | 75% | 75% | 75% | 75% |
Mutual Funds | 1.03% | 1.03% | 1.03% | 1.03% |
Foreign Portfolio Investors | 0.7% | 0.72% | 0.16% | 0.06% |
Individual Investors | 17.83% | 17.83% | 18.24% | 18.28% |
Others | 5.44% | 5.42% | 5.57% | 5.63% |
Gufic BioSciences Management
Name | Designation |
---|---|
Mr. Jayesh P Choksi | Chairman & Managing Director |
Mr. Pranav J Choksi | WholeTime Director & CEO |
Mr. Pankaj J Gandhi | Whole Time Director |
Mr. Dilip B Ghosh | Whole Time Director |
Dr. Balram H Singh | Non Exe.Non Ind.Director |
Mr. Rabi N Sahoo | Independent Director |
Mr. Gopal M Daptari | Independent Director |
Mr. Shreyas K Patel | Independent Director |
Mr. Shrirang V Vaidya | Independent Director |
Dr. Anu S Auora | Independent Director |
Gufic Biosciences Forecast
Price Estimates
Gufic Biosciences Corporate Action
Date | Purpose | Remarks |
---|---|---|
2023-08-11 | Quarterly Results & ESOP | |
2023-05-29 | Audited Results & Final Dividend | |
2023-02-10 | Quarterly Results | |
2022-11-11 | Quarterly Results | |
2022-08-11 | Quarterly Results |
- Company Name
- CMP
- Chg(%)
- Hindalco Inds.
- 493
- 5.5
- NTPC
- 246
- 3.6
- Hero Motocorp
- 3057
- 2.9
- Dr Reddys Labs
- 5587
- 2.9
- Divis Lab.
- 3765
- 2.7
- Company Name
- CMP
- Chg(%)
- Adani Enterp.
- 2414
- -2.5
- LTIMindtree
- 5210
- -1.0
- HCL Technologies
- 1235
- -0.6
- Tech Mahindra
- 1223
- -0.5
- Power Grid Corpn
- 200
- -0.5
Gufic BioSciences FAQs
What is Share Price of Gufic BioSciences ?
Gufic BioSciences share price is ₹286 As on 01 October, 2023 | 09:55
What is the Market Cap of Gufic BioSciences ?
The Market Cap of Gufic BioSciences is ₹2781.3 Cr As on 01 October, 2023 | 09:55
What is the P/E ratio of Gufic BioSciences ?
The P/E ratio of Gufic BioSciences is 35.1 As on 01 October, 2023 | 09:55
What is the PB ratio of Gufic BioSciences ?
The PB ratio of Gufic BioSciences is 8 As on 01 October, 2023 | 09:55